Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma.

Avelumab HIV Immune checkpoint inhibition Immunotherapy Merkel cell carcinoma Pembrolizumab Radiotherapy Sarcoidosis

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 23 11 2018
revised: 16 12 2018
accepted: 30 12 2018
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 24 1 2019
Statut: epublish

Résumé

This case report presents a HIV-positive 60-year old male with Merkel cell carcinoma of his right forearm and pulmonary sarcoidosis, who, after excisions and irradiations of the primary tumour site and subsequent lymph node metastases developed distant metastases. He received radiotherapy to symptomatic mediastinal lymph node metastases followed by Doxorubicin and, after two cycles, by the PD-1 inhibitor Pembrolizumab due to mixed response. Re-staging showed a para-mediastinal, radiotherapy-induced pneumonitis, which was treated by prednisolone due to clinical symptoms. In September 2017, the patient developed a solitary lymph node metastasis next to the right atrium, for which he received stereotactic radiotherapy. The systemic treatment with Pembrolizumab was replaced by the PD-L1 inhibitor Avelumab and is being continued since. The patient has been in complete remission for one year now and the HIV-infection is well-controlled.

Identifiants

pubmed: 30671549
doi: 10.1016/j.ctro.2018.12.004
pii: S2405-6308(18)30116-2
pmc: PMC6327905
doi:

Types de publication

Case Reports

Langues

eng

Pagination

42-45

Références

Science. 2008 Feb 22;319(5866):1096-100
pubmed: 18202256
J Am Acad Dermatol. 2008 Mar;58(3):375-81
pubmed: 18280333
Nature. 2009 Mar 12;458(7235):206-10
pubmed: 19078956
J Dtsch Dermatol Ges. 2009 Jun;7(6):521-5
pubmed: 19192166
Australas J Dermatol. 2009 Nov;50(4):249-56
pubmed: 19916967
J Am Acad Dermatol. 2010 Nov;63(5):751-61
pubmed: 20646783
Cancer Immunol Res. 2013 Jul;1(1):54-63
pubmed: 24416729
Front Oncol. 2014 Nov 28;4:325
pubmed: 25506582
Am Surg. 2015 Aug;81(8):802-6
pubmed: 26215243
Cancer Res. 2015 Dec 15;75(24):5228-34
pubmed: 26627015
Oncotarget. 2016 Jan 19;7(3):3403-15
pubmed: 26655088
N Engl J Med. 2016 Jun 30;374(26):2542-52
pubmed: 27093365
Chest. 2016 May;149(5):e133-6
pubmed: 27157227
Lancet Oncol. 2016 Oct;17(10):1374-1385
pubmed: 27592805
J Immunother Cancer. 2016 Dec 20;4:94
pubmed: 28031822
Ann Oncol. 2017 Dec 1;28(12):3104-3106
pubmed: 28950303
J Immunother Cancer. 2018 Jan 19;6(1):7
pubmed: 29347993
JAMA Oncol. 2018 Sep 1;4(9):e180077
pubmed: 29566106
J Thorac Oncol. 2018 Jul;13(7):1037-1042
pubmed: 29631035
J Thorac Oncol. 2018 Jul;13(7):874-876
pubmed: 29935842

Auteurs

Annett Linge (A)

OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany.
Department of Radiotherapy and Radiation Oncology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Helmholtz Association / Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Ricarda Rauschenberg (R)

National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Helmholtz Association / Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Department of Dermatology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Sophia Blum (S)

Institute and Policlinic of Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Petra Spornraft-Ragaller (P)

Department of Dermatology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Friedegund Meier (F)

National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Helmholtz Association / Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Department of Dermatology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Esther G C Troost (EGC)

OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany.
Department of Radiotherapy and Radiation Oncology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Helmholtz Association / Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

Classifications MeSH